Group B Streptococcus Infection Treatment Market Report Infographic Image

Published : February 2026

Pages : 250

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Group B Streptococcus Infection Treatment Market Report 2026

Name: Group B Streptococcus Infection Treatment Market Report 2026
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

By Treatment Type (Antibiotic Therapy, Intravenous Immunoglobulin (IVIG), Experimental Therapies), By Drug Class (Beta-Lactam Antibiotic, Clindamycin And Alternatives, Pipeline Therapies), By Route of Administration (Oral Administration, Intravenous Administration, Topical Application), By Patient Type (Newborns, Pregnant Women, Immunocompromised Patients, Elderly Population), By End User (Hospitals, Clinics, Research Institutions, Home Care Settings) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Purchase This Report Download Sample PDF

Item added to cart!

Group B Streptococcus Infection Treatment Market Overview

• Group B Streptococcus Infection Treatment market size has reached to $1.26 billion in 2025

• Expected to grow to $1.89 billion in 2030 at a compound annual growth rate (CAGR) of 8.6%

• Growth Driver: Rising Healthcare Expenditure Fueling The Growth Of The Market Due To Increasing Investment In Screening, Infrastructure, And Vaccine Development

• Market Trend: Advancements In Simplified Vaccine Manufacturing Enhancing Immunogenicity And Reducing Bacterial Carriage

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Group B Streptococcus Infection Treatment Market?

Group B Streptococcus infection treatment refers to the medical management of infections caused by Streptococcus agalactiae, which can affect newborns, pregnant women, and adults with weakened immunity. It commonly involves antibiotic therapy to reduce bacterial load and prevent complications. Its primary purpose is to eradicate GBS bacteria, prevent complications, and reduce the risk of transmission, especially from mother to newborn.

The main treatment types of Group B Streptococcus infection treatment include antibiotic therapy, intravenous immunoglobulin, and experimental therapies. Antibiotic therapy refers to the use of medications to eliminate or control bacterial infection caused by Group B Streptococcus. These treatments belong to drug classes such as beta-lactam antibiotic, clindamycin and alternatives, and pipeline therapies. The routes of administration include oral administration, intravenous administration, and topical application. The patient types include newborns, pregnant women, immunocompromised patients, and elderly population, and the end users are hospitals, clinics, research institutions, and home care settings.

Group B Streptococcus Infection Treatment Market Report bar graph

What Is The Group B Streptococcus Infection Treatment Market Size and Share 2026?

The group b streptococcus infection treatment market size has grown strongly in recent years. It will grow from $1.26 billion in 2025 to $1.36 billion in 2026 at a compound annual growth rate (CAGR) of 8.3%. The growth in the historic period can be attributed to increasing awareness of neonatal infections, expansion of prenatal care programs, widespread use of beta-lactam Antibiotics, growth in hospital-based screening protocols, availability of microbiological testing services.

What Is The Group B Streptococcus Infection Treatment Market Growth Forecast?

The group b streptococcus infection treatment market size is expected to see strong growth in the next few years. It will grow to $1.89 billion in 2030 at a compound annual growth rate (CAGR) of 8.6%. The growth in the forecast period can be attributed to increasing development of gbs vaccines, rising adoption of point-of-care diagnostics, growing focus on antimicrobial resistance management, expansion of molecular testing infrastructure, increasing emphasis on preventive maternal healthcare. Major trends in the forecast period include increasing adoption of rapid molecular diagnostic testing, rising focus on prenatal gbs screening programs, growing use of antibiotic stewardship protocols, expansion of pipeline therapies for gbs prevention, enhanced monitoring of maternal and neonatal outcomes.

Book your 30 minutes free consultation with our research experts

Global Group B Streptococcus Infection Treatment Market Segmentation

1) By Treatment Type: Antibiotic Therapy; Intravenous Immunoglobulin (IVIG); Experimental Therapies

2) By Drug Class: Beta-Lactam Antibiotic; Clindamycin And Alternatives; Pipeline Therapies

3) By Route of Administration: Oral Administration; Intravenous Administration; Topical Application

4) By Patient Type: Newborns; Pregnant Women; Immunocompromised Patients; Elderly Population

5) By End User: Hospitals; Clinics; Research Institutions; Home Care Settings

Subsegments:

1) By Antibiotic Therapy: Penicillin Based Antibiotics; Cephalosporin Antibiotics; Macrolide Antibiotics; Aminoglycoside Antibiotics

2) By Intravenous Immunoglobulin (IVIG): Standard Polyclonal Immunoglobulin; High Dose Immunoglobulin Therapy; Adjunctive Immunoglobulin Therapy

3) By Experimental Therapies: Vaccine Based Therapies; Monoclonal Antibody Therapies; Bacteriophage Therapies; Immunomodulatory Therapies

What Is The Driver Of The Group B Streptococcus Infection Treatment Market?

The rising healthcare expenditure is expected to people the growth of the group B streptococcus infection treatment market going forward. Healthcare expenditure refers to the total financial resources spent on medical services, preventive care, medications, infrastructure, and related health activities to maintain or improve population health. Healthcare expenditure is rising due to the increasing prevalence of chronic and infectious diseases, which drives sustained demand for long-term treatment, advanced therapies, and continuous medical care. Expanding healthcare expenditure strengthens group B Streptococcus infection treatment by increasing investment in prenatal screening, clinical infrastructure, and vaccine research, which together improve early detection, prevention, and effective management of GBS infections in mothers and newborns. For instance, in April 2025, according to the Office for National Statistics, a UK-based government organization, overall healthcare spending increased by 6.5% from 2023 to 2024, marking an acceleration compared with the 6.3% growth recorded in 2023. Therefore, the rising healthcare expenditure is driving the growth of the group B streptococcus infection treatment industry.

Key Players In The Global Group B Streptococcus Infection Treatment Market

Major companies operating in the group b streptococcus infection treatment market are Merck & Co. Inc., Pfizer Inc., Sanofi S.A., Novartis AG, GlaxoSmithKline plc, Biological E. Limited, Serum Institute of India Pvt. Ltd., Walvax Biotechnology Co. Ltd., Vaxcyte Inc., Bharat Biotech International Limited, Clover Biopharmaceuticals Ltd., Biovac Institute (Pty) Ltd., Inventprise Inc., BioNet Asia Co. Ltd., GeneOne Life Science Inc., Alopexx Enterprises LLC, Wellstat Vaccines LLC, MinervaX ApS, and ShanghAI Zerun Biotechnology Co. Ltd.

Global Group B Streptococcus Infection Treatment Market Trends and Insights

Major companies operating in the group B streptococcus infection treatment market are focusing on developing innovative products, such as polysaccharide conjugate vaccines, to reduce asymptomatic bacterial carriage. Polysaccharide conjugate vaccines are immunizations in which bacterial surface sugars are chemically linked to a carrier protein to enhance immune recognition and generate a strong, long-lasting protective response, especially in infants and young children. For instance, in September 2023, Omniose, a US-based biotechnology company, announced a grant award of up to $3.0 million from the National Institute of Allergy and Infectious Diseases at the U.S. National Institutes of Health to support the development of a Group B Streptococcus (GBS) vaccine. The vaccine’s unique feature lies in its aim to achieve high efficacy through a highly simplified manufacturing approach. Omniose’s platform leverages synthetic biology and a one-step enzymatic process within a single re-engineered E. coli cell to produce GBS polysaccharide conjugate vaccines, eliminating conventional chemical conjugation steps. This process preserves 100% of sialic acid residues on each capsular polysaccharide, a factor shown to be critical for inducing strong functional antibody responses against specific GBS serotypes.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Group B Streptococcus Infection Treatment Market?

In September 2024, MinervaX ApS, a Denmark-based biotechnology company developing a novel prophylactic vaccine against Group B Streptococcus (GBS), partnered with Wacker Biotech B.V. to scale up the manufacturing of active protein ingredients for MinervaX’s GBS vaccine. Through this collaboration, MinervaX and Wacker Biotech aim to ensure robust late-stage clinical and commercial supply, enabling maternal vaccination to prevent adverse pregnancy outcomes and life-threatening infections in infants, as well as vaccination of older or at-risk adults. Wacker Biotech B.V. is a Germany-based company specializing in E. coli processes, technology transfer, process validation, and process characterization to support stable, high-quality vaccine production for global patient populations.

Regional Insights

North America was the largest region in the group B streptococcus infection treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Group B Streptococcus Infection Treatment Market?

The group B streptococcus infection treatment market consists of revenues earned by entities by providing services such as prenatal screening and diagnostic testing, microbiological culture and molecular testing, clinical consultations for infection management, and antibiotic administration and monitoring. The market value includes the value of related goods sold by the service provider or included within the service offering. The group B streptococcus infection treatment market also includes sales of intrapartum prophylactic formulations, rapid diagnostic kits, molecular testing assays, and supportive care products. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Group B Streptococcus Infection Treatment Market Report 2026?

The group b streptococcus infection treatment market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the group b streptococcus infection treatment industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

Group B Streptococcus Infection Treatment Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2026	$1.36 billion
Revenue Forecast In 2035	$1.89 billion
Growth Rate	CAGR of 8.3% from 2026 to 2035
Base Year For Estimation	2025
Actual Estimates/Historical Data	2020-2025
Forecast Period	2026 - 2030 - 2035
Market Representation	Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered	Treatment Type, Drug Class, Route of Administration, Patient Type, End User
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	Merck & Co. Inc., Pfizer Inc., Sanofi S.A., Novartis AG, GlaxoSmithKline plc, Biological E. Limited, Serum Institute of India Pvt. Ltd., Walvax Biotechnology Co. Ltd., Vaxcyte Inc., Bharat Biotech International Limited, Clover Biopharmaceuticals Ltd., Biovac Institute (Pty) Ltd., Inventprise Inc., BioNet Asia Co. Ltd., GeneOne Life Science Inc., Alopexx Enterprises LLC, Wellstat Vaccines LLC, MinervaX ApS, and ShanghAI Zerun Biotechnology Co. Ltd.
Customization Scope	Request for Customization
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Group B Streptococcus Infection Treatment Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Group B Streptococcus Infection Treatment Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Group B Streptococcus Infection Treatment Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Group B Streptococcus Infection Treatment Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Digitalization, Cloud, Big Data & Cybersecurity

4.1.3 Industry 4.0 & Intelligent Manufacturing

4.1.4 Artificial Intelligence & Autonomous Intelligence

4.1.5 Fintech, Blockchain, Regtech & Digital Finance

4.2. Major Trends

4.2.1 Increasing Adoption Of Rapid Molecular Diagnostic Testing

4.2.2 Rising Focus On Prenatal Gbs Screening Programs

4.2.3 Growing Use Of Antibiotic Stewardship Protocols

4.2.4 Expansion Of Pipeline Therapies For Gbs Prevention

4.2.5 Enhanced Monitoring Of Maternal And Neonatal Outcomes

5. Group B Streptococcus Infection Treatment Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Clinics

5.3 Diagnostic Laboratories

5.4 Maternity Care Centers

5.5 Research Institutions

6. Group B Streptococcus Infection Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Group B Streptococcus Infection Treatment Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Group B Streptococcus Infection Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Group B Streptococcus Infection Treatment Market Size, Comparisons And Growth Rate Analysis

7.3. Global Group B Streptococcus Infection Treatment Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Group B Streptococcus Infection Treatment Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Group B Streptococcus Infection Treatment Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Group B Streptococcus Infection Treatment Market Segmentation

9.1. Global Group B Streptococcus Infection Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Antibiotic Therapy, Intravenous Immunoglobulin (IVIG), Experimental Therapies

9.2. Global Group B Streptococcus Infection Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Beta-Lactam Antibiotic, Clindamycin And Alternatives, Pipeline Therapies

9.3. Global Group B Streptococcus Infection Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Oral Administration, Intravenous Administration, Topical Application

9.4. Global Group B Streptococcus Infection Treatment Market, Segmentation By Patient Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Newborns, Pregnant Women, Immunocompromised Patients, Elderly Population

9.5. Global Group B Streptococcus Infection Treatment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals, Clinics, Research Institutions, Home Care Settings

9.6. Global Group B Streptococcus Infection Treatment Market, Sub-Segmentation Of Antibiotic Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Penicillin Based Antibiotics, Cephalosporin Antibiotics, Macrolide Antibiotics, Aminoglycoside Antibiotics

9.7. Global Group B Streptococcus Infection Treatment Market, Sub-Segmentation Of Intravenous Immunoglobulin (IVIG), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Standard Polyclonal Immunoglobulin, High Dose Immunoglobulin Therapy, Adjunctive Immunoglobulin Therapy

9.8. Global Group B Streptococcus Infection Treatment Market, Sub-Segmentation Of Experimental Therapies, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Vaccine Based Therapies, Monoclonal Antibody Therapies, Bacteriophage Therapies, Immunomodulatory Therapies

10. Group B Streptococcus Infection Treatment Market Regional And Country Analysis

10.1. Global Group B Streptococcus Infection Treatment Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Group B Streptococcus Infection Treatment Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Group B Streptococcus Infection Treatment Market

11.1. Asia-Pacific Group B Streptococcus Infection Treatment Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Group B Streptococcus Infection Treatment Market, Segmentation By Treatment Type, Segmentation By Drug Class, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Group B Streptococcus Infection Treatment Market

12.1. China Group B Streptococcus Infection Treatment Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Group B Streptococcus Infection Treatment Market, Segmentation By Treatment Type, Segmentation By Drug Class, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Group B Streptococcus Infection Treatment Market

13.1. India Group B Streptococcus Infection Treatment Market, Segmentation By Treatment Type, Segmentation By Drug Class, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Group B Streptococcus Infection Treatment Market

14.1. Japan Group B Streptococcus Infection Treatment Market Overview

14.2. Japan Group B Streptococcus Infection Treatment Market, Segmentation By Treatment Type, Segmentation By Drug Class, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Group B Streptococcus Infection Treatment Market

15.1. Australia Group B Streptococcus Infection Treatment Market, Segmentation By Treatment Type, Segmentation By Drug Class, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Group B Streptococcus Infection Treatment Market

16.1. Indonesia Group B Streptococcus Infection Treatment Market, Segmentation By Treatment Type, Segmentation By Drug Class, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Group B Streptococcus Infection Treatment Market

17.1. South Korea Group B Streptococcus Infection Treatment Market Overview

17.2. South Korea Group B Streptococcus Infection Treatment Market, Segmentation By Treatment Type, Segmentation By Drug Class, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Group B Streptococcus Infection Treatment Market

18.1. Taiwan Group B Streptococcus Infection Treatment Market Overview

18.2. Taiwan Group B Streptococcus Infection Treatment Market, Segmentation By Treatment Type, Segmentation By Drug Class, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Group B Streptococcus Infection Treatment Market

19.1. South East Asia Group B Streptococcus Infection Treatment Market Overview

19.2. South East Asia Group B Streptococcus Infection Treatment Market, Segmentation By Treatment Type, Segmentation By Drug Class, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Group B Streptococcus Infection Treatment Market

20.1. Western Europe Group B Streptococcus Infection Treatment Market Overview

20.2. Western Europe Group B Streptococcus Infection Treatment Market, Segmentation By Treatment Type, Segmentation By Drug Class, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Group B Streptococcus Infection Treatment Market

21.1. UK Group B Streptococcus Infection Treatment Market, Segmentation By Treatment Type, Segmentation By Drug Class, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Group B Streptococcus Infection Treatment Market

22.1. Germany Group B Streptococcus Infection Treatment Market, Segmentation By Treatment Type, Segmentation By Drug Class, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Group B Streptococcus Infection Treatment Market

23.1. France Group B Streptococcus Infection Treatment Market, Segmentation By Treatment Type, Segmentation By Drug Class, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Group B Streptococcus Infection Treatment Market

24.1. Italy Group B Streptococcus Infection Treatment Market, Segmentation By Treatment Type, Segmentation By Drug Class, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Group B Streptococcus Infection Treatment Market

25.1. Spain Group B Streptococcus Infection Treatment Market, Segmentation By Treatment Type, Segmentation By Drug Class, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Group B Streptococcus Infection Treatment Market

26.1. Eastern Europe Group B Streptococcus Infection Treatment Market Overview

26.2. Eastern Europe Group B Streptococcus Infection Treatment Market, Segmentation By Treatment Type, Segmentation By Drug Class, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Group B Streptococcus Infection Treatment Market

27.1. Russia Group B Streptococcus Infection Treatment Market, Segmentation By Treatment Type, Segmentation By Drug Class, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Group B Streptococcus Infection Treatment Market

28.1. North America Group B Streptococcus Infection Treatment Market Overview

28.2. North America Group B Streptococcus Infection Treatment Market, Segmentation By Treatment Type, Segmentation By Drug Class, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Group B Streptococcus Infection Treatment Market

29.1. USA Group B Streptococcus Infection Treatment Market Overview

29.2. USA Group B Streptococcus Infection Treatment Market, Segmentation By Treatment Type, Segmentation By Drug Class, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Group B Streptococcus Infection Treatment Market

30.1. Canada Group B Streptococcus Infection Treatment Market Overview

30.2. Canada Group B Streptococcus Infection Treatment Market, Segmentation By Treatment Type, Segmentation By Drug Class, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Group B Streptococcus Infection Treatment Market

31.1. South America Group B Streptococcus Infection Treatment Market Overview

31.2. South America Group B Streptococcus Infection Treatment Market, Segmentation By Treatment Type, Segmentation By Drug Class, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Group B Streptococcus Infection Treatment Market

32.1. Brazil Group B Streptococcus Infection Treatment Market, Segmentation By Treatment Type, Segmentation By Drug Class, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Group B Streptococcus Infection Treatment Market

33.1. Middle East Group B Streptococcus Infection Treatment Market Overview

33.2. Middle East Group B Streptococcus Infection Treatment Market, Segmentation By Treatment Type, Segmentation By Drug Class, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Group B Streptococcus Infection Treatment Market

34.1. Africa Group B Streptococcus Infection Treatment Market Overview

34.2. Africa Group B Streptococcus Infection Treatment Market, Segmentation By Treatment Type, Segmentation By Drug Class, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Group B Streptococcus Infection Treatment Market Regulatory and Investment Landscape

36. Group B Streptococcus Infection Treatment Market Competitive Landscape And Company Profiles

36.1. Group B Streptococcus Infection Treatment Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Group B Streptococcus Infection Treatment Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Group B Streptococcus Infection Treatment Market Company Profiles

36.3.1. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

36.3.5. GlaxoSmithKline plc Overview, Products and Services, Strategy and Financial Analysis

37. Group B Streptococcus Infection Treatment Market Other Major And Innovative Companies

Biological E. Limited, Serum Institute of India Pvt. Ltd., Walvax Biotechnology Co. Ltd., Vaxcyte Inc., Bharat Biotech International Limited, Clover Biopharmaceuticals Ltd., Biovac Institute (Pty) Ltd., Inventprise Inc., BioNet Asia Co. Ltd., GeneOne Life Science Inc., Alopexx Enterprises LLC, Wellstat Vaccines LLC, MinervaX ApS, Shanghai Zerun Biotechnology Co. Ltd.

38. Global Group B Streptococcus Infection Treatment Market Competitive Benchmarking And Dashboard

39. Upcoming Startups in the Market

40. Key Mergers And Acquisitions In The Group B Streptococcus Infection Treatment Market

41. Group B Streptococcus Infection Treatment Market High Potential Countries, Segments and Strategies

41.1 Group B Streptococcus Infection Treatment Market In 2030 - Countries Offering Most New Opportunities

41.2 Group B Streptococcus Infection Treatment Market In 2030 - Segments Offering Most New Opportunities

41.3 Group B Streptococcus Infection Treatment Market In 2030 - Growth Strategies

41.3.1 Market Trend Based Strategies

41.3.2 Competitor Strategies

42. Appendix

42.1. Abbreviations

42.2. Currencies

42.3. Historic And Forecast Inflation Rates

42.4. Research Inquiries

42.5. The Business Research Company

42.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Group B Streptococcus Infection Treatment Market, Overview Of Key Products - Product Examples

Table 2: Global Group B Streptococcus Infection Treatment Market Attractiveness, Factor-Wise Evaluation

Table 3: Global Group B Streptococcus Infection Treatment Market, Supply Chain Analysis

Table 4: Global Group B Streptococcus Infection Treatment Market, Major Raw Material Providers

Table 5: Global Group B Streptococcus Infection Treatment Market, Major Resource Providers

Table 6: Global Group B Streptococcus Infection Treatment Market, Major Manufacturers (Suppliers)

Table 7: Global Group B Streptococcus Infection Treatment Market, Major Distributors And Channel Partners

Table 8: Global Group B Streptococcus Infection Treatment Market, Key Technologies & Future Trends

Table 9: Global Group B Streptococcus Infection Treatment Market, Major Trends

Table 10: Global Group B Streptococcus Infection Treatment Market, Major End Users

Table 11: Global Group B Streptococcus Infection Treatment Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Table 12: Global Group B Streptococcus Infection Treatment Historic Market Growth, 2020-2025, $ Billion

Table 13: Global Group B Streptococcus Infection Treatment Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Table 14: Global Group B Streptococcus Infection Treatment Market - TAM, US$ Billion, 2025

Table 15: Global Group B Streptococcus Infection Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 16: Global Group B Streptococcus Infection Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 17: Global Group B Streptococcus Infection Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 18: Global Group B Streptococcus Infection Treatment Market, Segmentation By Patient Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 19: Global Group B Streptococcus Infection Treatment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 20: Global Group B Streptococcus Infection Treatment Market, Sub-Segmentation Of Antibiotic Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 21: Global Group B Streptococcus Infection Treatment Market, Sub-Segmentation Of Intravenous Immunoglobulin (IVIG), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 22: Global Group B Streptococcus Infection Treatment Market, Sub-Segmentation Of Experimental Therapies, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 23: Global Group B Streptococcus Infection Treatment Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 24: Global Group B Streptococcus Infection Treatment Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 25: Asia-Pacific, Group B Streptococcus Infection Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 26: Asia-Pacific, Group B Streptococcus Infection Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 27: Asia-Pacific, Group B Streptococcus Infection Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 28: China, Group B Streptococcus Infection Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 29: China, Group B Streptococcus Infection Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 30: China, Group B Streptococcus Infection Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 31: India, Group B Streptococcus Infection Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 32: India, Group B Streptococcus Infection Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 33: India, Group B Streptococcus Infection Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 34: Japan, Group B Streptococcus Infection Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 35: Japan, Group B Streptococcus Infection Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 36: Japan, Group B Streptococcus Infection Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 37: Australia, Group B Streptococcus Infection Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 38: Australia, Group B Streptococcus Infection Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 39: Australia, Group B Streptococcus Infection Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 40: Indonesia, Group B Streptococcus Infection Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 41: Indonesia, Group B Streptococcus Infection Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 42: Indonesia, Group B Streptococcus Infection Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 43: South Korea, Group B Streptococcus Infection Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 44: South Korea, Group B Streptococcus Infection Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 45: South Korea, Group B Streptococcus Infection Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 46: Taiwan, Group B Streptococcus Infection Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 47: Taiwan, Group B Streptococcus Infection Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 48: Taiwan, Group B Streptococcus Infection Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 49: South East Asia, Group B Streptococcus Infection Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 50: South East Asia, Group B Streptococcus Infection Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 51: South East Asia, Group B Streptococcus Infection Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 52: Western Europe, Group B Streptococcus Infection Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 53: Western Europe, Group B Streptococcus Infection Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 54: Western Europe, Group B Streptococcus Infection Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 55: UK, Group B Streptococcus Infection Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 56: UK, Group B Streptococcus Infection Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 57: UK, Group B Streptococcus Infection Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 58: Germany, Group B Streptococcus Infection Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 59: Germany, Group B Streptococcus Infection Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 60: Germany, Group B Streptococcus Infection Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 61: France, Group B Streptococcus Infection Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 62: France, Group B Streptococcus Infection Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 63: France, Group B Streptococcus Infection Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 64: Italy, Group B Streptococcus Infection Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 65: Italy, Group B Streptococcus Infection Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 66: Italy, Group B Streptococcus Infection Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 67: Spain, Group B Streptococcus Infection Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 68: Spain, Group B Streptococcus Infection Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 69: Spain, Group B Streptococcus Infection Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 70: Eastern Europe, Group B Streptococcus Infection Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 71: Eastern Europe, Group B Streptococcus Infection Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 72: Eastern Europe, Group B Streptococcus Infection Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 73: Russia, Group B Streptococcus Infection Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 74: Russia, Group B Streptococcus Infection Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 75: Russia, Group B Streptococcus Infection Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 76: North America, Group B Streptococcus Infection Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 77: North America, Group B Streptococcus Infection Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 78: North America, Group B Streptococcus Infection Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 79: USA, Group B Streptococcus Infection Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 80: USA, Group B Streptococcus Infection Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 81: USA, Group B Streptococcus Infection Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 82: Canada, Group B Streptococcus Infection Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 83: Canada, Group B Streptococcus Infection Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 84: Canada, Group B Streptococcus Infection Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 85: South America, Group B Streptococcus Infection Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 86: South America, Group B Streptococcus Infection Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 87: South America, Group B Streptococcus Infection Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 88: Brazil, Group B Streptococcus Infection Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 89: Brazil, Group B Streptococcus Infection Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 90: Brazil, Group B Streptococcus Infection Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 91: Middle East, Group B Streptococcus Infection Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 92: Middle East, Group B Streptococcus Infection Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 93: Middle East, Group B Streptococcus Infection Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 94: Africa, Group B Streptococcus Infection Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 95: Africa, Group B Streptococcus Infection Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 96: Africa, Group B Streptococcus Infection Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 97: Global Group B Streptococcus Infection Treatment Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 98: Global Group B Streptococcus Infection Treatment Market - Company Scoring Matrix

Table 99: Upcoming Startups

Table 100: Merck & Co. Inc. Financial Performance

Table 101: Pfizer Inc. Financial Performance

Table 102: Sanofi S.A. Financial Performance

Table 103: Novartis AG Financial Performance

Table 104: GlaxoSmithKline plc Financial Performance

Table 105: Global Group B Streptococcus Infection Treatment Market, Competitive Benchmarking (In USD Billions)

Table 106: Global Group B Streptococcus Infection Treatment Market, Competitive Dashboard

Table 107: Global Group B Streptococcus Infection Treatment Market Size Gain ($ Billion), 2025 – 2030 By Country

Table 108: Global, Group B Streptococcus Infection Treatment Market Size Gain ($ Billion), Segmentation By Treatment Type, 2025 – 2030

Table 109: Global, Group B Streptococcus Infection Treatment Market Size Gain ($ Billion), Segmentation By Drug Class, 2025 – 2030

Table 110: Global, Group B Streptococcus Infection Treatment Market Size Gain ($ Billion), Segmentation By Route of Administration, 2025 – 2030

List Of Figures

Figure 1: Global Group B Streptococcus Infection Treatment Market, Overview Of Key Products - Product Examples

Figure 2: Global Group B Streptococcus Infection Treatment Market Attractiveness, Factor-Wise Evaluation

Figure 3: Global Group B Streptococcus Infection Treatment Market, Supply Chain Analysis

Figure 4: Global Group B Streptococcus Infection Treatment Market, Major Raw Material Providers

Figure 5: Global Group B Streptococcus Infection Treatment Market, Major Resource Providers

Figure 6: Global Group B Streptococcus Infection Treatment Market, Major Manufacturers (Suppliers)

Figure 7: Global Group B Streptococcus Infection Treatment Market, Major Distributors And Channel Partners

Figure 8: Global Group B Streptococcus Infection Treatment Market, Key Technologies & Future Trends

Figure 9: Global Group B Streptococcus Infection Treatment Market, Major Trends

Figure 10: Global Group B Streptococcus Infection Treatment Market, Major End Users

Figure 11: Global Group B Streptococcus Infection Treatment Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 12: Global Group B Streptococcus Infection Treatment Historic Market Growth, 2020-2025, $ Billion

Figure 13: Global Group B Streptococcus Infection Treatment Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Figure 14: Global Group B Streptococcus Infection Treatment Market - TAM, US$ Billion, 2025

Figure 15: Global Group B Streptococcus Infection Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 16: Global Group B Streptococcus Infection Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 17: Global Group B Streptococcus Infection Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 18: Global Group B Streptococcus Infection Treatment Market, Segmentation By Patient Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 19: Global Group B Streptococcus Infection Treatment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 20: Global Group B Streptococcus Infection Treatment Market, Sub-Segmentation Of Antibiotic Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 21: Global Group B Streptococcus Infection Treatment Market, Sub-Segmentation Of Intravenous Immunoglobulin (IVIG), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 22: Global Group B Streptococcus Infection Treatment Market, Sub-Segmentation Of Experimental Therapies, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 23: Global Group B Streptococcus Infection Treatment Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 24: Global Group B Streptococcus Infection Treatment Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 25: Asia-Pacific, Group B Streptococcus Infection Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 26: Asia-Pacific, Group B Streptococcus Infection Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 27: Asia-Pacific, Group B Streptococcus Infection Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 28: China, Group B Streptococcus Infection Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 29: China, Group B Streptococcus Infection Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 30: China, Group B Streptococcus Infection Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 31: India, Group B Streptococcus Infection Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 32: India, Group B Streptococcus Infection Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 33: India, Group B Streptococcus Infection Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 34: Japan, Group B Streptococcus Infection Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 35: Japan, Group B Streptococcus Infection Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 36: Japan, Group B Streptococcus Infection Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 37: Australia, Group B Streptococcus Infection Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 38: Australia, Group B Streptococcus Infection Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 39: Australia, Group B Streptococcus Infection Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 40: Indonesia, Group B Streptococcus Infection Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 41: Indonesia, Group B Streptococcus Infection Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 42: Indonesia, Group B Streptococcus Infection Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 43: South Korea, Group B Streptococcus Infection Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 44: South Korea, Group B Streptococcus Infection Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 45: South Korea, Group B Streptococcus Infection Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 46: Taiwan, Group B Streptococcus Infection Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 47: Taiwan, Group B Streptococcus Infection Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 48: Taiwan, Group B Streptococcus Infection Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 49: South East Asia, Group B Streptococcus Infection Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 50: South East Asia, Group B Streptococcus Infection Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 51: South East Asia, Group B Streptococcus Infection Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 52: Western Europe, Group B Streptococcus Infection Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 53: Western Europe, Group B Streptococcus Infection Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 54: Western Europe, Group B Streptococcus Infection Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 55: UK, Group B Streptococcus Infection Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 56: UK, Group B Streptococcus Infection Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 57: UK, Group B Streptococcus Infection Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 58: Germany, Group B Streptococcus Infection Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 59: Germany, Group B Streptococcus Infection Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 60: Germany, Group B Streptococcus Infection Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 61: France, Group B Streptococcus Infection Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 62: France, Group B Streptococcus Infection Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 63: France, Group B Streptococcus Infection Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 64: Italy, Group B Streptococcus Infection Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 65: Italy, Group B Streptococcus Infection Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 66: Italy, Group B Streptococcus Infection Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 67: Spain, Group B Streptococcus Infection Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 68: Spain, Group B Streptococcus Infection Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 69: Spain, Group B Streptococcus Infection Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 70: Eastern Europe, Group B Streptococcus Infection Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 71: Eastern Europe, Group B Streptococcus Infection Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 72: Eastern Europe, Group B Streptococcus Infection Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 73: Russia, Group B Streptococcus Infection Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 74: Russia, Group B Streptococcus Infection Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 75: Russia, Group B Streptococcus Infection Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 76: North America, Group B Streptococcus Infection Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 77: North America, Group B Streptococcus Infection Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 78: North America, Group B Streptococcus Infection Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 79: USA, Group B Streptococcus Infection Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 80: USA, Group B Streptococcus Infection Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 81: USA, Group B Streptococcus Infection Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 82: Canada, Group B Streptococcus Infection Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 83: Canada, Group B Streptococcus Infection Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 84: Canada, Group B Streptococcus Infection Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 85: South America, Group B Streptococcus Infection Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 86: South America, Group B Streptococcus Infection Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 87: South America, Group B Streptococcus Infection Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 88: Brazil, Group B Streptococcus Infection Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 89: Brazil, Group B Streptococcus Infection Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 90: Brazil, Group B Streptococcus Infection Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 91: Middle East, Group B Streptococcus Infection Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 92: Middle East, Group B Streptococcus Infection Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 93: Middle East, Group B Streptococcus Infection Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 94: Africa, Group B Streptococcus Infection Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 95: Africa, Group B Streptococcus Infection Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 96: Africa, Group B Streptococcus Infection Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 97: Global Group B Streptococcus Infection Treatment Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 98: Global Group B Streptococcus Infection Treatment Market - Company Scoring Matrix

Figure 99: Upcoming Startups

Figure 100: Merck & Co. Inc. Financial Performance

Figure 101: Pfizer Inc. Financial Performance

Figure 102: Sanofi S.A. Financial Performance

Figure 103: Novartis AG Financial Performance

Figure 104: GlaxoSmithKline plc Financial Performance

Figure 105: Global Group B Streptococcus Infection Treatment Market, Competitive Benchmarking (In USD Billions)

Figure 106: Global Group B Streptococcus Infection Treatment Market, Competitive Dashboard

Figure 107: Global Group B Streptococcus Infection Treatment Market Size Gain ($ Billion), 2025 – 2030 By Country

Figure 108: Global, Group B Streptococcus Infection Treatment Market Size Gain ($ Billion), Segmentation By Treatment Type, 2025 – 2030

Figure 109: Global, Group B Streptococcus Infection Treatment Market Size Gain ($ Billion), Segmentation By Drug Class, 2025 – 2030

Figure 110: Global, Group B Streptococcus Infection Treatment Market Size Gain ($ Billion), Segmentation By Route of Administration, 2025 – 2030

Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

Anti-Inflammatory Biologics Market Revenue Outlook: Strategic Insights and Forecast to 2029

CAGR of 10.8% Projected for Anti-Tumor Drugs Market From 2025 to 2029

Future Demand and Leading Companies Shaping the Asthma Disease Market to 2029

Comprehensive Forecast: Asthma Therapeutics Market Share, Growth, and Opportunities Through 2029

Antibacterial Products Market Report 2026 - Global Outlook – By Product (Body Wash, Body Moisturizer, Hand Cream and Lotion, Hand Soaps, Hand Sanitizers, Facial Cleansers, Facial Mask ), By Form (Bar, Liquid ), By Distri...

Hospital-Acquired Infection Control Market Report 2026 - Global Outlook – By Product (Sterilizers, Disinfectors, Endoscope Reprocessors, Microbial Testing Instruments, Consumables, Disinfectants, Infection Prevention And...

Antibiotics Market Report 2026 - Global Outlook – By Drug Class (Penicillin, Cephalosporin, Aminoglycosides, Tetracycline, Macrolides, Fluoroquinolones, Sulfonamides, Other Classes), By Spectrum Of Activity (Broad-spectr...

Pseudomonas Aeruginosa Infection Treatment Market Report 2026 - Global Outlook – By Medication (Monotherapy, Combination Therapy), By Drug Class (Aminoglycoside, Cephalosporin, Carbapenem, Monobactum, Other Drug Classes)...

Glycopeptide Antibiotics Market Report 2026 - Global Outlook – By Drug (Vancomycin, Dalbavancin, Oritavancin, Other Drugs), By Route of Administration (Oral, Parenteral, Other Routes), By Indication (Skin And Structure I...

Peptide Antibiotics Market Report 2026 - Global Outlook – By Type (Ribosomal Synthesized Peptide Antibiotics, Non-Ribosomal Synthesized Peptide Antibiotics), By Drugs (Daptomycin, Dalbavancin, Telavancin, Other Drugs), B...

Infectious Disease Therapeutics Market Report 2026 - Global Outlook – By Type (Drugs, Vaccines), By Disease (Tuberculosis, HIV/AIDS, Influenza, Hepatitis, Other Diseases), By End-User (Hospitals And Clinics, Retail Pharm...

Frequently Asked Questions

How big is the Group B Streptococcus Infection Treatment Market?

The Group B Streptococcus Infection Treatment market was valued at $1.26 billion in 2025, increased to $1.36 billion in 2026, and is projected to reach $1.89 billion by 2030.

What is the Group B Streptococcus Infection Treatment market growth?

The global Group B Streptococcus Infection Treatment market is expected to grow at a CAGR of 8.6% from 2026 to 2035 to reach $1.89 billion by 2035.

Who are the key players in Group B Streptococcus Infection Treatment market?

Some Key Players in the Group B Streptococcus Infection Treatment market Include, Merck & Co. Inc., Pfizer Inc., Sanofi S.A., Novartis AG, GlaxoSmithKline plc, Biological E. Limited, Serum Institute of India Pvt. Ltd., Walvax Biotechnology Co. Ltd., Vaxcyte Inc., Bharat Biotech International Limited, Clover Biopharmaceuticals Ltd., Biovac Institute (Pty) Ltd., Inventprise Inc., BioNet Asia Co. Ltd., GeneOne Life Science Inc., Alopexx Enterprises LLC, Wellstat Vaccines LLC, MinervaX ApS, and ShanghAI Zerun Biotechnology Co. Ltd. .

What is the anticipated growth trend for the Group B Streptococcus Infection Treatment market?

Major trend in this market includes: Advancements In Simplified Vaccine Manufacturing Enhancing Immunogenicity And Reducing Bacterial Carriage. For further insights on this market. request a sample here

Which region has the most growth potential in the Group B Streptococcus Infection Treatment market?

North America was the largest region in the group B streptococcus infection treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the group b streptococcus infection treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.